641 / 1241
Detection of invasive carcinomas
• Highly variable uptake
• No subgroup that will not benefit from FDG-PET
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast
cancer patients scheduled for neoadjuvant chemotherapy.
Koolen BB et al. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1830-8.
9